Navigation Links
EntreMed Reports Third Quarter 2013 Financial Results
Date:11/14/2013

ROCKVILLE, Md., Nov. 14, 2013 /PRNewswire/ -- EntreMed, Inc. (NASDAQ: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of a variety of cancers, today reported financial results for the three and nine-month periods ending September 30, 2013. 

(Logo: http://photos.prnewswire.com/prnh/20010620/ENMDLOGO )

EntreMed reported a net loss for the third quarter of 2013 of ($1.4 million), or ($0.05) per share. This compares with a net loss of ($1.2 million), or ($0.05) per share, for the same period last year.
For the first nine months of 2013 the reported net loss was ($4.4 million), or ($0.17) per share as compared to ($14.2 million), or ($0.81) per share for 2012.  The 2012 year to date reported net loss included non-cash interest charges associated with our financing in 2012 ($10.0 million for the nine months ended September 30, 2012).  Excluding this non-cash interest, net loss for the first nine months of 2012 was ($4.1 million), or ($0.23) per share.

As of September 30, 2013, EntreMed had cash and cash equivalents of approximately $15.9 million.

Sara B. Capitelli, EntreMed's Vice President, Finance & Principal Accounting Officer, commented on the third quarter results, "Our financial results for the third quarter are in line with our expectations.  Our research and development expenses for the third quarter increased compared to the previous year primarily due to costs associated with the Company's crossover bioavailability and food effect study of ENMD-2076, along with the clinical development of ENMD-2076 in China during 2013.  We anticipate fourth quarter operating expenses to increase as we execute on our clinical development plan in the US and China."

Dr. Ken
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. EntreMed Reports First Quarter 2012 Financial Results
2. EntreMed Announces Initiation Of Phase 2 Trial In Triple-negative Breast Cancer
3. EntreMed Reports Second Quarter 2012 Financial Results
4. Dana-Farber Cancer Institutes Ursula A. Matulonis, MD Article on EntreMeds ENMD-2076 Published in the European Journal of Cancer
5. EntreMed Announces Publication Of Preclinical Results For ENMD-2076 In Triple-negative Breast Cancer
6. PNAS Publishes Preclinical Results of EntreMeds 2ME2 for Multiple Sclerosis
7. EntreMed Announces Initiation Of Phase 2 Trial In Advanced/Metastatic Soft Tissue Sarcoma
8. EntreMed To Raise $10.7 Million In Registered Direct Offering
9. EntreMed Reports Fourth Quarter And Year-End 2012 Financial Results And Business Outlook For 2013
10. EntreMed Announces Changes to Board of Directors and CEO Appointment
11. Patent Issued In U.S. For EntreMeds 2ME2 In Rheumatoid Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2014)...  Eli Lilly and Company (NYSE: ... study in genetically engineered mice examining combination therapy ... N3pG and beta-secretase inhibitor BACE (LY2811376). Data results ... removing clumps of amyloid-beta protein in the brain ... to Alzheimer,s disease (AD) – than use of ...
(Date:7/11/2014)... 11, 2014 /PRNewswire-iReach/ -- VAPETEK™, Inc. has announced ... for use in portable vaporizers, which contains CBD, ... in cannabis, cannabidiol offers consumers a THC-free product ... other vaporizer technology. Photo - ... 483 different compounds which are currently known, two ...
(Date:7/11/2014)... HILL, N.C. , July 11, 2014 /PRNewswire/ ... of pharmaceutical marketing and, consequently, organizations are turning ... for patients. As part of this ... it,s important to educate, communicate and engage patients ... disease awareness to patient empowerment. By mapping the ...
Breaking Medicine Technology:New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 2New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 3VAPETEK Releases CBD-Infused eLiquid For The Consumer Market 2New Study Uses Six-Step Patient Journey as Framework for Consumer-Focused Marketing Opportunities 2
... 21, 2011 ClinStar, LLC , an established ... Europe to the pharmaceutical and biotechnology industry, announced today ... Marcus Evans 6th Annual Clinical Research in Emerging ... (Logo: http://photos.prnewswire.com/prnh/20110719/SF36975LOGO ) The ...
... On the 1-year anniversary of Congress approving the District ... Patients, Cooperative (DCPC), a District-based non-profit organization and Safe ... Safe Access, will hold a press conference on Wednesday, ... John A. Wilson Building, 1350 Pennsylvania Ave. NW.   ...
Cached Medicine Technology:ClinStar to Present on Conducting Clinical Trials in Russia 2DC Patients' Cooperative to Announce Operations Hiatus Until City Shows Leadership 2
(Date:7/13/2014)... Advanced boilers are preferred over conventional boilers ... fuels, produce high-capacity power, emit fewer pollutants, and ... and climate change concerns, many countries have implemented ... and pollutants coming from fossilfuel-based power plants.North America ... boilers market., The global power rental market is ...
(Date:7/13/2014)... Fuel additives are chemicals, which are added to ... and so on, in order to enhance their performance. ... effects caused by fuels and improving the combustion properties ... economies of scale in the long run, but, in ... the fuel products. , The various fuel additive types ...
(Date:7/13/2014)... According to a new market ... by Component (processor, GPU, DSP, connectivity), Technology Node ... Geography - Forecast and Analysis to 2014-2020", published ... Computing Market is expected to reach $61.70 Billion ... from 2014 to 2020. , Browse 71 market ...
(Date:7/13/2014)... MarketsandMarkets recently conducted a study on the “3D ... Layout and Animation; Image Reconstruction]: Global Advancements, Market ... and studies the major market drivers, restraints, and ... Middle East and Africa, Asia-Pacific and Latin America. ... the 3D imaging market, providing an in-depth comparative ...
(Date:7/13/2014)... New York, New York (PRWEB) July 13, 2014 ... much to bring attention to the cancer risks associated ... a chance to tell their story to federal regulators, ... of a U.S. Food & Drug Administration (FDA) ... Liebhard LLP reports. According to the Rochester Democrat ...
Breaking Medicine News(10 mins):Health News:North America Advanced Boilers Market is Expected to Reach $518.7billion by 2019 - New Report by MicroMarket Monitor 2Health News:North America Advanced Boilers Market is Expected to Reach $518.7billion by 2019 - New Report by MicroMarket Monitor 3Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 2Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 3Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 4Health News:Heterogeneous Mobile Processing & Computing Market Worth $61.70 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Heterogeneous Mobile Processing & Computing Market Worth $61.70 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Heterogeneous Mobile Processing & Computing Market Worth $61.70 Billion by 2020 – New Report by MarketsandMarkets 4Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 2Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 3Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 4Health News:Couple Who Brought Attention to Morcellator Cancer Risks Testify on Second Day of FDA Advisory Panel Meeting, Bernstein Liebhard LLP Reports 2Health News:Couple Who Brought Attention to Morcellator Cancer Risks Testify on Second Day of FDA Advisory Panel Meeting, Bernstein Liebhard LLP Reports 3Health News:Couple Who Brought Attention to Morcellator Cancer Risks Testify on Second Day of FDA Advisory Panel Meeting, Bernstein Liebhard LLP Reports 4
... E-Book Offers Options During National Infertility Awareness ... Blossom Consulting, LLC, a,Chicago-based infertility consultancy with ... their free E-Book, Financing Your Infertility,Treatment, available ... E-Book addresses the financial,aspects of infertility, and ...
... cardio health , , TUESDAY, Nov. 6 (HealthDay News) -- ... practitioners at risk for heart disease in as little ... individuals followed the maintenance phase of the diet -- ... and other markers for heart disease, experts report. ...
... 6, 2007 People who have a mother with Alzheimers disease ... those individuals whose fathers are afflicted, according to a new study ... The study is published in this weeks online edition ... the first to compare brain metabolism among cognitively normal people who ...
... This release is also availabe in Spanish . ... of Granada have devised a new technique to determine the ... was carried out by Dr. Pedro Manuel Garamendi Gonzlez ... Inmaculada Alemn Aguilera . This is of special interest in the ...
... -- Each year, pharmaceutical companies invest millions of dollars to ... because of side effects found only during human clinical trials. ... organ transplants continues to increase. In the past 10 years, ... by a University of Missouri-Columbia physics researcher might present new ...
... seven cities, ... including Largo, Fla., ORLANDO, Fla., Nov. ... techniques supports the widespread use of the American,Heart Association,s new 2005 ... AHA,s Scientific Sessions on November 4 in,Orlando. Lead author, Tom P. ...
Cached Medicine News:Health News:Lotus Blossom Consulting Announces E-Book on Infertility Treatment Financing 2Health News:Atkins Diet Can Raise Heart Risks 2Health News:Atkins Diet Can Raise Heart Risks 3Health News:Atkins Diet Can Raise Heart Risks 4Health News:A maternal link to Alzheimer's disease 2Health News:A maternal link to Alzheimer's disease 3Health News:New technique to determine the age of immigrant minors through ribs and teeth 2Health News:MU research team makes progress toward 'printing' organs 2Health News:MU research team makes progress toward 'printing' organs 3Health News:Study Released at AHA Shows Survival to Hospital Discharge After Cardiac Arrest Doubles With Improved CPR and Impedance Threshold Device 2
... 50 and 100 ms scans to perform truly ... and proprietary cardiac analysis software take full advantage ... x-ray detector rings to image the lumen of ... wall motion. The EBT C300 also supports traditional ...
Angled 45 Degrees to Right, 9.5mm blade, gently curved .5x .25mm blunt tips; Lower blade is 0.5mm longer; 14mm from mid screw to tip; (Available in left and right;) overall length 120mm; Stainless ...
Angled 45 Degrees to Right, 9.5mm blade, gently curved .5x .25mm blunt tips; Lower blade is 0.5mm longer; 14mm from mid screw to tip; (Available in left and right; ) overall length 120mm; Stainless ...
0.12 1x2 tips on a 2.5mm platform; Stainless Steel Tip; 32mm shaft; Titanium Handle....
Medicine Products: